Lv11
8 积分 2024-02-26 加入
An update on current and emerging drug treatments for idiopathic pulmonary fibrosis
3小时前
待确认
Nutritional and Medical Applications of Spirulina Microalgae
1个月前
已完结
Food and drug industry applications of microalgae Spirulina platensis: A review
1个月前
已完结
Bioinspired pH-Responsive Microalgal Hydrogels for Oral Insulin Delivery with Both Hypoglycemic and Insulin Sensitizing Effects
3个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
9个月前
已完结
Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
9个月前
已完结
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
9个月前
已完结
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
10个月前
已完结
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
10个月前
已完结
Fibroblast growth factor 2 decreases bleomycin‐induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation
11个月前
已完结
皖公网安备34019202002308
